SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001654954-21-000290
Filing Date
2021-01-08
Accepted
2021-01-08 17:29:42
Documents
6
Period of Report
2021-02-24

Document Format Files

Seq Description Document Type Size
1 PRELIMINARY PROXY STATEMENT azrx_pre14ajan2021.htm PRE 14A 352079
2 IMAGE azrx_pre14ajan2021003.jpg GRAPHIC 1160
3 IMAGE azrx_pre14ajan2021004.jpg GRAPHIC 1237
4 IMAGE azrx_pre14ajan2021005.jpg GRAPHIC 1176
5 IMAGE azurrx_logo000.jpg GRAPHIC 6071
6 IMAGE azurrxproxy.jpg GRAPHIC 3334
  Complete submission text file 0001654954-21-000290.txt   371873
Mailing Address 1615 SOUTH CONGRESS AVENUE SUITE 103 DELRAY BEACH FL 33445
Business Address 1615 SOUTH CONGRESS AVENUE SUITE 103 DELRAY BEACH FL 33445 646-699-7855
AzurRx BioPharma, Inc. (Filer) CIK: 0001604191 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 001-37853 | Film No.: 21518489
SIC: 2834 Pharmaceutical Preparations